Acevedoblalock0417

Degree of cross-linking and stiffness of injectable hydrogels were controlled by composition. The gels hold promise as injectable drug or cell carrier and as bioink.We present the Brownian dynamics simulation of an active colloidal suspension in two dimensions, where the self-propulsion speed of a colloid is regulated according to the local density sensed by it. The role of concentration-dependent motility in the phase-separation of colloids and their dynamics is investigated in detail. Interestingly, the system phase separates at a very low packing fraction (Φ≈ 0.125) at higher self-propulsion speeds (Pe), into a dense phase coexisting with a homogeneous phase and attains a long-range crystalline order beyond the transition point. The transition point is quantified here from the local density profiles and local and global-bond order parameters. We have shown that the characteristics of the phase diagram are qualitatively akin to the active Brownian particle (ABP) model. Moreover, our investigation reveals that the density-dependent motility amplifies the slow-down of the directed speed, which facilitates phase-separation even at low packing fractions. The effective diffusivity shows a crossover from quadratic rise to a power-law behavior of exponent 3/2 with Pe in the phase-separated regime. Furthermore, we have shown that the effective diffusion decreases exponentially with packing fraction in the phase-separated regime, while it shows a linear decrease in the single phase regime.The diagnosis of gastrointestinal (GI) tract diseases is frequently performed in the clinic, so it is crucial to develop high-performance contrast agents for real-time and non-invasive imaging examination of the GI tract. Herein, we show a novel method to synthesize a neodymium (Nd) chelate, Nd-diethylenetriaminepentaacetic acid (Nd-DTPA), on a large scale without byproducts for spectral computed tomography (CT) and second near-infrared window imaging of the GI tract in vivo. The Nd-DTPA was simply generated by heating the mixture of Nd2O3 and DTPA in water at 85 °C for 2 h. This dual-modal imaging agent has the advantages of a simple and green synthesis route, no need of purification process, high yield (86.24%), large-scale production capability (>10 g in lab synthesis), good chemical stability and excellent water solubility (≈2 g mL-1). Moreover, the Nd-DTPA emitted strong near-infrared fluorescence at 1308 nm, and exhibited superior X-ray attenuation ability compared to clinical iohexol. selleck products The proposed Nd-DTPA can integrate the complementary merits of dual-modal imaging to realize spatial-temporal and highly sensitive imaging of the GI tract in vivo, and accurate diagnosis of the location of intestinal obstruction and monitor its recovery after surgery. The developed highly efficient method for the gram-scale synthesis of Nd-DTPA and the proposed spectral CT and second near-infrared window dual-modal imaging strategy provide a promising route for accurate visualization of the GI tract in vivo.Traditional methods of depleting tumor-associated myeloid cells via chemotherapy can easily lead to the re-recruitment of them, eventually resulting in chemo-resistance and presenting obstacles in immunotherapy. Herein, we report a nano-educator (NE) that when loaded with all trans retinoic acid (ATRA) and anti-PD-1 antibodies (aPD-1) instructs myeloid cells to assist T cells towards revitalizing anti-PD-1 therapy. In vivo, ATRA converts myeloid-derived suppressor cells (MDSCs) into dendritic cells (DCs), which are essential for anti-PD-1 therapy, while intervening in the polarization of macrophages. Furthermore, aPD-1-armed T cells reboot anti-tumor immunity after suppression relief, which exposes tumor-specific antigens and in turn promotes the maturation of transformed DCs. The nano-platform provides shelter for vulnerable immunomodulatory agents and durable drug release to stimulate intensive immune modulation. We established three types of tumor-bearing mice models with different myeloid cell contents to show the spatiotemporal complementarity of ATRA and aPD-1. The NE re-educates the tumor's guard to assist T cells in enhanced immunotherapy, broadening the application of aPD-1 in the treatment of anti-PD-1-resistant tumors.Elevated levels of reactive oxygen species (ROS) are implicated in the onset and progression of many diseases, e.g., virus infection, ischemic stroke and neurodegenerative diseases. ROS-scavenging nanomaterials have attracted particular interest. Here, we report the development of a natural protein nanocage named Dps for in vitro and in vivo antioxidant treatment by inhibiting the Fenton reaction, a critical step in ROS generation and interconversion. Systematic surface engineering enabled cell penetration, good colloidal stability, and facile purification of Dps. With its intrinsic ferroxidase activity consuming both H2O2 and Fe2+, Dps not only protects human cells from oxidative stress but also effectively alleviates ROS-induced inflammation in a mouse dermatitis model. The protection is triggered by elevated H2O2 and thereby, in principle, avoids ROS imbalances. Thus, Dps has potential as a new bionano platform for different purposes, such as antiaging, anti-inflammation and cosmetics.Developing efficient electrocatalysts for the neutral oxygen evolution reaction (OER) is important but still challenging. Herein, by combining density functional theory calculations and experiments, we have demonstrated that the decoration of RuO2 can effectively accelerate the OER kinetics of Co3O4 in neutral electrolyte. High activity (365 mV at 10 mA cm-2) and decent stability (up to 100 h) are achieved by RuO2-decorated Co3O4 in 1 M PBS electrolyte.Chemotherapy benefits can be greatly boosted by developing multifunctional prodrug nanoplatforms with high drug loading and spatially and temporally regulated drug release. Here, we report a tumorous heterogeneity-activatable prodrug (PTX-S-BDP), bridging paclitaxel (PTX) and BODIPY (BDP-OH) with a redox stress responsive linker, for fluorescence imaging-guided chemotherapy. PTX-S-BDP was co-assembled with Pluronic F-127 to obtain PTX-S-BDP nanoparticles (PTX-S-BDP NPs) with water dispersibility. The emerging nanoplatform contributes to visual chemotherapy modality, by virtue of refined cellular real-time localization of chemotherapeutics through the fluorescence of BDP-OH. In addition, in vitro experiments verify that PTX-S-BDP NPs exhibit comparable cytotoxicity to Taxol, superior cellular imaging, and better cell selectivity to cancer cells. The novel prodrug nanoplatform overcomes the challenge of PTX hydrophobicity, low drug loading, and uncontrolled drug retention and release, and is anticipated to provide some reference value in the development of prodrugs in the future.